FantasticSearch

Scroll to: TopResults

Explore European Union Legislation by Asking a Legal Question

assisted-checkbox

filter-instruction-1
positive-filters
negative-filters
act-filter tabs-all

parameters-title

query

assisted-checkbox:

result-title

total 16

Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical

article  annex_II

CELEX:  31997R0467

Additional pharmaceutical intermediates, i.e. compounds used for the manufacture of finished pharmaceutical products, to receive duty-free treatment CN code CAS RN Name 2843 30 00 12192-57-3 (alpha-D-glucopyranosylthio) gold 2903 69 90 42074-68-0 1-chloro-2-(chlorodiphenylmethyl) benzene 76283-09-5 alpha,4-dibromo-2-fluorotoluene 2906 29 90 104265-58-9 2-[(1 S,2R)-6-fluoro-2-hydroxy-1 -isopropyl-1,2,3,4-tetrahydro-2-naphthyl] ethyl p-toluenesulfonate 2907 29 90 700-13-0 2,3,5-tximethylhydroquinone 2909 50 90 63659-16-5 4-[2-(cyclopropylmethoxy) ethyl] phenol 2914 40 90 80-75-1 11-alpha-hydroxypregn-4-ene-3,20-dione 2914 50 00 2107-69-9 5,6-dimethoxyindan-1 -one 24916-90-3 9-beta,11-beta-epoxy-17,21-dihydroxy-l6-alpha-methylpregna-l,4-diene-3,20-dione 2914 70 90 83881-08-7 21-chloro-9-beta, 11 -beta-epoxy-17-hydroxy-16-alpha-methylpregna-1,4-diene-3,20-dione 2915 39 90 979-02-2 20-oxopregna-5,l 6-dien-3-beta-yl acetate 2915 90 20 638-41-5 pentyl chloroformate 2916 39 00 49708-81-8 trans-4-(p-chlorophenyl)cyclohexanecarboxylic acid 2917 19 90 48059-97-8 (E)-oct-4-ene-1,8-dioic acid 71170-82-6 triethyl 3-bromopropane-1,1,1-tricarboxylate 2917 39 80
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical

article  annex_II

CELEX:  31997R0467

27932-00-9 indan-5-yl hydrogen phenylmalonate 2918 13 00 2743-38-6 dibenzoyl-L-tartaric acid 2918 17 00 4358-88-7 ethyl DL-mandelate 2918 19 80 56188-04-6 {(1 R,3R,5S)-3,5-dihydroxy-2-[(E)-(3S)-3-hydroxyoct-1 -enyl]cyclopentyl}acetic acid 2918 29 90 167678-46-8 3-chloroformyl-o-tolyl acetate 2918 30 00 56105-81-8 (R)-2-(3-benzoylphenyl) propionic acid 22161-86-0 (RS)-2-(3-benzoylphenyl) propionic acid 78834-75-0 enthyl 7-chloro-2-oxoheptanoate 1944-63-4 3-[(3aS,4S,7aS)-7a-methyl-1,5-dioxooctahydro-1 H-inden-4-yl]propionic acid 39562-17-9 methyl 2-(3-nitrobenzylidene)-3-oxobutyrate 2918 90 90 26159-31-9 (RS)-2-(6-methoxy-2-naphthyl)propionic acid 105560-93-8 methyl (2R,3S)-2,3-epoxy-3-(4-methoxyphenyl) propionate 40098-26-8 methyl 7-[(3RS)-3-hydroxy-5-oxocyclopent-1-enyl]heptanoate 2921 19 80 4261-68-1 (2-chloroethyl) diisopropylamine hydrochloride 2921 59 90 122-75-8 N, N'-dibenzylethylenediammonium di (acetate) 2922 19 00 126456-43-7 (1S,2R)-1-aminoindan-2-ol 68047-07-4 4'-[2-(dimethylamino) ethoxy]-2-phenylbutyrophenone 2922 30 00 784-38-3 2-amino-5-chloro-2'-fluorobenzophenone 156732-13-7
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical

article  annex_II

CELEX:  31997R0467

(S)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one 2922 49 70 37441-29-5 5-amino-2,4,6-triiodoisophthaloyl dichloride 42854-62-6 benzyl L-alaninate--p-toluenesulfonic acid (1:1) 39878-87-0 (-)-alpha-(chloroformyl) benzylammonium chloride 54527-73-0 2-(N-methylbenzylamino) ethyl 3-aminobut-2-enoate 81677-60-3 methyl (4-nitrophenyl)-L-alaninate 949-99-5 3-(4-nitrophenyl)-L-alanine 2924 10 00 153758-31-7 (2S)-2-amino-3-hydroxy-N-pentylpropionamide--oxalic acid (1:1) 138531-07-4 L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-o L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysine 2924 29 90 40188-45-2 3'-acetyl-4'-hydroxybutyranilide 1149-26-4 N-(benzyloxycarbonyl)-L-valine 116661-86-0 (2S,3S)-3-(tert-butoxycarbonylamino)-2-hydroxy-4-phenylbutyric acid 144163-85-9 tert-butyl [(1S,3S,4S)-4-amino-1-benzyl-3-hydroxy-5-phenylpentyl] carbamate 149451-80-9 tert-butyl [(1S,2S)-1-benzyl-2,3-dihydroxypropyl] carbamate 98737-29-2 tert-butyl {(S)-alpha-[(S)-oxiranyl]phenethyl}carbamate 0-00-0 2-chloro-N-[2-(2-chlorobenzoyl)-4-nitrophenyl] acetamide 125971-96-2
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical

article  annex_II

CELEX:  31997R0467

2-[alpha-(4-fluorobenzoyl)benzyl]-4-methyl-3-oxovaleranilide 32981-85-4 methyl (2R,3S)-3-benzamido-2-hydroxy-3-phenylpropionate 2925 19 80 151860-15-0 meso-N-benzyl-3-nitrocyclopropane-1,2-dicarboximide 97338-03-9 ethyl (S)-3-(4-aminopheynl)-2-phthalimidopropionate hydrochloride 94213-26-0 ethyl (S)-3-{4-[bis(2-chloroethyl)amino]phenyl}-2-phthalimidopropionate hydrochloride 2926 90 80 58311-73-2 (Z)-(2-cyanovinyl)trimethylammonium p-toluenesulfonate 133481-10-4 ethyl (l-cyanocyclohexl)acetate 123632-23-5 4-(2,2,3,3-tetrafluoropropoxy)cinnamonitrile 2928 00 90 94213-23-7 (Z)-[cyano(2,3-dichlorophenyl)methylene]carbazamidine 2930 90 16 159453-24-4 N-(benzyloxycarbonyl)-S-phenyl-L-cysteine 2930 90 70 159878-02-1 benzyl (1 R,2S)-3-chloro-2-hydroxy-1 -(phenylthiomethyl)propylcarbamate 136511-43-8 ethyl N-{2-[(acetylthio)methyl]-3-(o-tolyl)-1-oxopropyl}-L-methionate 2932 19 00 97148-39-5 ammonium (Z)-2-methoxyimino-2-(2-furyl)acetate 2932 29 80 517-23-7 alpha-acetyl-gamma-butyrolactone 6559-91-7 4'-demethylepipodophyllotoxin 39521-49-8 (3aR,4bS,4R,4aS,5aS)-4-(5,5-dimethyl-1,3-dioxolan-2-yl)hexahydrocyclopropa[3,4]cyclopenta[l,2-b]furan-o 2(3H)-one 39746-01-5
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical

article  annex_II

CELEX:  31997R0467

(3aR,4R,5R,6aS)-4-formyl-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate 976-70-5 3-oxopregn-4-ene-21,17-alpha-carbolactone 2932 99 50 32981-86-5 10-deacetylbaccatin III 2932 99 70 7512-17-6 2-acetamido-2-deoxy-beta-D-glucopyranose 79944-37-9 trans-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol 125971-94-0 tert-butyl [(4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxolan-4-yl]acetate 467-55-0 3-beta-hydroxy-5-alpha-spirostan-12-one 533-31-3 3,4-(methylenedioxy)phenol 2933 11 90 6150-97-6 magnesium bis [(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1 H-pyrazol-4-yl)methylamino]methane- sulfonate 2933 19 90 27511-79-1 3-aminopyrazole-4-carboxamide hemisulfate 2933 29 90 4897-25-0 5-chloro-1-methyl-4-nitroimidazole 2933 39 95 142057-79-2 (RS)-2[(1 -benzyl-4-piperidyl)methyl]-5,6-dimethoxyindan-l -one 120014-07-5 2-[(l-benzyl-4-piperidyl)methylene]-5,6-dimethoxyindan-1-one 6935-27-9 benzyl(2-pyridy l)amine 87848-95-1 6-bromo-2-pyridyl-p-tolyl ketone 32998-95-1 N-(tert-butyl)-3-methylpyridine-2-carboxamide 84449-80-9 1-[2-(4-carboxyphenoxy)ethyl]piperidinium chloride 83949-32-0 4-carboxy-4-phenylpiperidinium p-toluenesulfonate 38092-89-6
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical

article  annex_II

CELEX:  31997R0467

8-chloro-6,11-dihydro-11-(l-methyl-4-piperidylidene)-5H-benzo[5,6]cyclohepta[l,2-b]pyridine 31255-57-9 3-[2-(3-chlorophenyl)ethyl]pyridine-2-carbonitrile 107256-31-5 3-[2-(3-chlorophenyl)ethyl]-2-pyridyl 1 -methyl-4-piperidyl ketone hydrochloride 6298-19-7 2-chloro-3-pyridylamine 5424-11-3 2,2-diphenyl-4-piperidinovaleronitrile 108555-25-5 1-[2-(4-methoxyphenyl)ethyl]-4-piperidylamine dihydrochloride 4046-24-6 5-(l -methyl-4-piperidyl)-5H-dibenzo[a,d]cyclohepten-5-ol hydrochloride 139886-04-7 1-methyl-1,2,5,6-tetrahydropyridine-3-carbaldehyde (E)-O-methyloxime hydrochloride 70708-28-0 1-(2-pyridyl)-3-(pyrrolidin-1-yl)-1-(p-tolyl)propan-1-ol 1619-34-7 quinuclidin-3-ol 2933 40 10 105956-96-5 7-[3-(tert-butoxycarbonylamino)pyrrolidin-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroc quinoline-3-carboxylic acid 86393-33-1 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 112811-72-0 1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 98349-25-8 ethyl 1 -cyclopropyl-6,7-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate 2933 40 90 159878-04-3
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical

article  annex_II

CELEX:  31997R0467

benzyl (1S,2S)-3-[3S,4aS,8aS)-3-tert-butylcarbamoylperhydro-2-isoquinolyl]-2-hydroxy-1-(phenylthioc methyl)propylcarbamate 159989-64-7 (3S,4aS,8aS)-N-(tert-butyl)-2-[(2S,3S)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-(phenylthio)butyl] perhydroisoquinoline-3-carboxamide 159989-65-8 (3S,4aS,8aS)-N-(tert-butyl)-2-[(2S,3S)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-(phenylthio)butyl] perhydroisoquinoline-3-carboxamide—methanesulfonic acid (1:1) 120578-03-2 3-[(E)-2-(7-chloro-2-quinolyl)vinyl]benzaldehyde 1087-69-0 (9S,13S,14S)-3-methoxymorphinan hydrochloride 64228-78-0 pentamethylene bis {3-[10-(3,4-dimethoxybenzyl)-6,7-dimethoxy-1,2,3,4-tetrahydro-2-isoquinolyl] propionate]- -oxalic acid (1:2) 2933 59 70 75128-73-3 2-[(2-acetamido-6-oxo-6,9-dihydro-1H-purin-9-yl)methoxy]ethyl acetate 3056-33-5 N-(9-acetyl-6-oxo-6,9-dihydro-1H-purin-2-yl)acetamide 10310-21-1 2-amino-6-chloropurine 124832-31-1 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-(benzyloxycarbonyl)-L-valinate 150378-17-9 (2R,4S)-2-benzyl-5-[2-(tert-butylcarbamoyl)-4-(3-pyridylmethyl)piperazin-1-yl]-4-hydroxy-N-[(1S,2R)-2-hydroxyindan-1-yl]valeramide 157810-81-6
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical

article  annex_II

CELEX:  31997R0467

(2R,4S)-2-benzyl-5-[2-(tert-butylcarbamoyl)-4-(3-pyridylmethyl)piperazin-1-yl]-4-hydroxy-N-[(lS,2R)-c 2-hydroxyindan-1-yl]valeramide sulfate 150323-35-6 (3S)-1-(tert-butoxycarbonyl)-3-(tert-butylcarbamoyl)piperazine 41202-32-8 1-(2-chlorophenyl)piperazine hydrochloride 13078-15-4 1-(3-chlorophenyl)piperazine hydrochloride 71-30-7 cytosine 149062-75-9 1,3-dichloro-6,7,8,9,1 0,1 2-hexahydroazepino[2,1 -b]quinazoline hydrochloride 41202-77-1 1-(2,3-dichlorophenyl)piperazine hydrochloride 56177-80-1 2-ethoxy-5-fluoropyrimidin-4(1 H)-one 112733-45-6 ethyl (7-chloro-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-l -yl)acetate 59703-00-3 4-ethyl-2,3-dioxopiperazine-l-carbonyl chloride 64090-19-3 1-(4-fluorophenyl)piperazine dihydrochloride 147539-21-7 isopropyl[2-(piperazin-1-yl)-3-pyridyl]amine 35386-24-4 1-(2-methoxyphenyl)piperazine 5464-78-8 1-(2-methoxyphenyl)piperazine hydrochloride 145012-50-6 (7RS,9aRS)-perhydropyrido[l,2-a]pyrazin-7-ylmethanol 2210-93-7 1-phenylpiperazinium chloride 111641-17-9 4-(piperazin-1-yl)-2,6-bis(pyrrolidin-1-yl)pyrimidine 68-94-0 purin-6(1 H)-one 70849-60-4 1-(o-tolyl)piperazine hydrochloride 2933 69 80 58909-39-0
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical

article  annex_II

CELEX:  31997R0467

tetrahydro-2-methyl-3-thioxo-1,2,4-triazine-5,6-dione 2933 79 00 135297-22-2 (3S,4R)-3-[(R)-1-(tert-butyldimethylsilyloxy)ethyl]-4-[(lR,3S)-3-methoxy-2-oxocyclohexyl]azetidin-2-one 141646-08-4 1-|[(cyclohexyloxy)carbonyl]oxy}ethyl 1 -(1 -hydroxyethyl)-5-methoxy-2-oxo-1,2,5,6,7,8,8 a,8b-octahydroazeto*c [2,1 -a]isoindole-4-carboxylate 132127-34-5 (3R,4S)-3-hydroxy-4-phenylazetidin-2-one 75363-99-4 p-nitrobenzyl (2R,5R,6S)-6-[(R)-1-hydroxyethyl]-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate 141316-45-2 potassium 1 -(1 -hydroxyethyl)-5-methoxy-2-oxo-1,2,5,6,7,8,8 a,8b-octahydroazeto[2,1 -a]isoindole-4-carbc oxylate 2933 90 60 59467-64-0 [7-chloro-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-yl]methylamine 59469-29-3 [7-chloro-5-(2-fluorophenyl)-2,3-dihydro-1 H-l,4-benzodiazepin-2-ylmethyl]ammonium bis(maleate) 59467-69-5 8-chloro-6-(2-fluorophenyl)-1-methyl-3a,4-dihydro-3H-imidazo[l,5-a][l,4]benzodiazepine 59469-63-5 7-chloro-5-(2-fluorophenyl)-3-methyl-2-(nitromethylene)-2,3-dihydro-1 H-1,4-benzodiazepine 4-oxide 59467-63-9 7-chloro-5-(2-fluorophenyl)-2(nitromethylene)-2,3-dihydro-1 H-1,4-benzodiazepine 2933 90 95 130404-91-0
Council Regulation (EC) No 467/97 of 3 March 1997 providing for duty-free treatment for specified pharmaceutical active ingredients bearing an 'international non-proprietary name' (INN) from the World Health Organization and specified products used for the manufacture of finished pharmaceuticals and withdrawing duty-free treatment as pharmaceutical products from certain INNs whose predominant use is not pharmaceutical

article  annex_II

CELEX:  31997R0467

N-[(R)-2-({(R)-2-[(2-adamantyloxycarbonyl)amino]-3-(lH-indol-3-yl)-2-methyl-1-oxopropyl}amino)-1- phenylethyl]succinamic acid-1-deoxy-1-methylamino-D-glucitol (1:1) 122536-48-5 3-[(S)-3-(L-alanylamino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3- carboxylic acid hydrochloride 122536-91-8 7-{(S)-3-[(S)-2-(tert-butoxycarbonylamino)-1-oxopropylamino]pyrrolidin-1-yl}-1-cyclopropyl-6-fluoro-4- oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid 134575-17-0 tert-butyl meso-3-azabicyclo[3.1.0]hex-6-ylcarbamate 122536-66-7 tert-butyl [(S)-1-methyl-2-oxo-2-[(S)-pyrrolidin-3-ylamino]ethyl}carbamate 140629-77-2 tert-butyl [(RS)-pyrrolidin-3-yl] carbamate 100361-18-0 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid 38150-27-5 5-chloro-2-[3-(hydroxymethyl)-5-methyl-4H-1,2,4-triazol-4-yl]ben2Ophenone 36916-19-5 5-chloro-2-(3-methyl-4H-1,2,4-triazol-4-yl)benzophenone 54196-62-2 2',5-dichloro-2-[3-(hydroxymethyl)-5-methyl-4H-1,2,4-triazol-4-yl]benzophenone 54196-61-1 2',5-dichloro-2-(3-methyl-4H-1,2,4-triazol-4-yl)benzophenone 141113-28-2